Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Adult Patients with Active Mild to Moderate Ulcerative Colitis [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating the efficacy and safety of Live SK08 Powder in adults with active mild to moderate ulcerative co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Live SK08 Powder

Snippet

Sponsor: Guangzhou Zhiyi Biotechnology Co., Ltd. | Conditions: Ulcerative Colitis (UC) | Phase 2 | Status: NOT_YET_RECRUITING